SCHEMBL6028638

SCHEMBL6028638

CC1(C)CC(=O)C2=C(C1)NC(CBr)=C(C(=O)O)C2c1ccccc1Cl

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 5/20 0.53
KMT2A Q03164 5/20 0.44
ALDH1A1 P00352 4/20 0.44
KDM4E B2RXH2 3/20 0.44
HSD17B10 Q99714 3/20 0.44
GAA P10253 2/20 0.44
HPGD P15428 2/20 0.44
CASP1 P29466 1/20 0.44
CASP7 P55210 1/20 0.44
MEN1 O00255 3/20 0.42
MAPT P10636 3/20 0.42
MAPK1 P28482 2/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
LMNA P02545 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
GSK3A P49840 3/20 0.42
TSHR P16473 3/20 0.42
GLA P06280 1/20 0.42
NPSR1 Q6W5P4 3/20 0.41
HTT P42858 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5810204 0.87 NPSR1 (0.54) GSK3BALDH1A1KDM4EHSD17B10GAA
SCHEMBL5222526 0.85 GSK3B (0.60) GSK3BKMT2AALDH1A1KDM4EHSD17B10
SCHEMBL6027051 0.84 GSK3B (0.48) GSK3BKMT2AALDH1A1KDM4EHSD17B10
SCHEMBL5815747 0.76 NPSR1 (0.67) GSK3BALDH1A1KDM4EHSD17B10GAA
SCHEMBL5820269 0.75 HTR1A (0.60) GSK3BALDH1A1KDM4EHSD17B10GAA
SCHEMBL5813926 0.75 GSK3B (0.58) GSK3BKMT2AALDH1A1KDM4EHSD17B10
SCHEMBL3320698 0.74 KDM4E (0.60) GSK3BALDH1A1KDM4EHSD17B10GAA
SCHEMBL5810980 0.74 HTR1A (0.63) GSK3BALDH1A1KDM4EHSD17B10GAA
SCHEMBL6028346 0.74 HTR1A (0.63) GSK3BALDH1A1KDM4EHSD17B10GAA
SCHEMBL5815722 0.74 HTR1A (0.63) GSK3BALDH1A1KDM4EHSD17B10GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1663227-A2 DIHYDROPYRIDINE COMPOUNDS FOR TREATING OR PREVENTING METABOLIC DISORDERS Synta Pharmaceuticals Corporation (US) 2006-06-07 EP disclosed
WO-2005025507-A2 DIHYDROPYRIDINE COMPOUNDS FOR TREATING OR PREVENTING METABOLIC DISORDERS SYNTA PHAMACEUTICALS CORP. (US) 2005-03-24 WO disclosed